Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion

ClinicalTrials.gov ID: NCT01277302

Public ClinicalTrials.gov record NCT01277302. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Randomized Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This was a Phase IV multicenter, randomized, open-label study, with masking of the vision examiner, of the efficacy and safety of intravitreal ranibizumab 0.5 mg in subjects with macular edema following Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO).

Study identification

NCT ID
NCT01277302
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Genentech, Inc.
Industry
Enrollment
202 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2011 (Type not available)
Primary completion
Oct 2012 (Actual)
Completion
Oct 2012 (Actual)
Last update posted
Apr 23, 2014

2011 – 2012

United States locations

U.S. sites
42
U.S. states
20
U.S. cities
41
Facility City State ZIP Site status
Not listed Phoenix Arizona 85020 —
Not listed Tucson Arizona 85704 —
Not listed Beverly Hills California 90211 —
Not listed Chico California 95973 —
Not listed Mountain View California 94040 —
Not listed Oakland California 94609 —
Not listed San Francisco California 94107 —
Not listed Santa Ana California 92705 —
Not listed Santa Barbara California 93103 —
Not listed Torrance California 90503 —
Not listed Colorado Springs Colorado 80909 —
Not listed Golden Colorado 80401 —
Not listed New London Connecticut 06320 —
Not listed Altamonte Springs Florida 32701 —
Not listed Boynton Beach Florida 33426 —
Not listed Lakeland Florida 33805 —
Not listed Augusta Georgia 30909 —
Not listed Chicago Illinois 60637 —
Not listed Baltimore Maryland 21287 —
Not listed Hagerstown Maryland 21740 —
Not listed Boston Massachusetts 02114 —
Not listed Worcester Massachusetts 01605 —
Not listed Jackson Michigan 49201 —
Not listed Edina Minnesota 55435 —
Not listed Las Vegas Nevada 89144 —
Not listed Northfield New Jersey 08225 —
Not listed Teaneck New Jersey 07666 —
Not listed Rochester New York 14620 —
Not listed Charlotte North Carolina 28210 —
Not listed Camp Hill Pennsylvania 17011 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Pittsburgh Pennsylvania 15212 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed Ladson South Carolina 29456 —
Not listed West Columbia South Carolina 29169 —
Not listed Rapid City South Dakota 57701 —
Not listed Nashville Tennessee 37203 —
Not listed Abilene Texas 79606 —
Not listed Austin Texas 78705 —
Not listed Houston Texas 77030 —
Not listed San Antonio Texas 78240 —
Not listed The Woodlands Texas 77384 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01277302, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01277302 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →